Probuphine FDA Approval History
FDA Approved: Yes (First approved May 26, 2016)
Brand name: Probuphine
Generic name: buprenorphine
Dosage form: Implant
Company: Titan Pharmaceuticals, Inc.
Treatment for: Opiate Dependence
Probuphine (buprenorphine) is an opioid partial agonist subdermal implant for the treatment of opioid dependence.
Development Timeline for Probuphine
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.